|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Center for Complementary and Alternative Medicine (NCCAM) |
|---|---|
| Collaborator: |
National Institute of Neurological Disorders and Stroke (NINDS) |
| Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
| ClinicalTrials.gov Identifier: | NCT00065754 |
Purpose
This study examines the mechanisms, including brain imaging of placebo analgesia
| Condition | Intervention |
|---|---|
|
Irritable Bowel Syndrome |
Drug: placebo |
| Study Type: | Interventional |
| Study Design: | Randomized, Double-Blind, Factorial Assignment |
| Official Title: | Brain Imaging and Pain: Analysis of Placebo Analgesia |
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion criteria:
Exclusion criteria:
Contacts and Locations
More Information
| Study ID Numbers: | R01 AT001424-01 |
| Study First Received: | July 31, 2003 |
| Last Updated: | August 4, 2008 |
| ClinicalTrials.gov Identifier: | NCT00065754 History of Changes |
| Health Authority: | United States: Federal Government |
|
Placebo Analgesia Pain Brain mechanism Expectation |
|
Pathologic Processes Disease Digestive System Diseases Gastrointestinal Diseases Syndrome |
Colonic Diseases Irritable Bowel Syndrome Intestinal Diseases Colonic Diseases, Functional |